May 17, 2017 10:07 AM EDT
News Briefing

Deci­bel chief Holtz­man cham­pi­ons Fen­way as the new ‘hood in biotech; Aduro adds 2nd Keytru­da com­bo for can­cer

Shehla Shakoor

Managing Director

→ Deci­bel Ther­a­peu­tics CEO Steve Holtz­man isn’t just hop­ing to pi­o­neer new hear­ing drugs at his start­up. The Bio­gen vet is al­so cru­sad­ing to make …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Mi­crosoft-backed Enve­da rais­es $130M for drugs in I&I, obe­si­ty and oth­er ar­eas

As­traZeneca culls Phase 2 opi­oid use dis­or­der drug

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times